Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient

Clinical Transplantation

Volumn 24, Issue SUPPL. 22, 2010, Pages 60-65

  Sakai, Ken ^a   Takasu, Jirou ^a   Nihei, Hiroshi ^a   Yonekura, Takashi ^a   Aoki, Yujirou ^a   Kawamura, Takeshi ^a   Mizuiri, Sonoo ^a   Aikawa, Atsushi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Plasma exchange; Protocol biopsy; Renal transplant; Rituximab

Indexed keywords

BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; VALSARTAN; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; SYMPTOM; TREATMENT OUTCOME; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RENAL REPLACEMENT THERAPY;

ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PLASMA EXCHANGE; PROTEINURIA; RENAL DIALYSIS; TREATMENT OUTCOME; ANTIBODIES, MONOCLONAL, MURINE-DERIVED;

EID: 77954498906     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01279.x     Document Type: Article

References (22)

1. Artero M, Biava C, Amend W. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992, 92:375.
2. Andresdottir MB, Ajubi N, Croockewit S. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999, 14:2650.
3. Abbot KC, Sawyers ES, Oliver JD. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001, 37:366.
4. Cibrik DM, Kaplan B, Campbell DA. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003, 3:64.
5. Savin VJ, Sharma R, Sharma M. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Eng J Med 1996, 334:878.
6. Artero ML, Sharma R, Savin VJ. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994, 23:574.
7. Deegens JK, Andresdottir MB, Croockewit S. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis. After renal transplant. Transpl Int 2004, 17:151.
8. Iguchi Y, Tanabe K, Yagisawa T. Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients. Ther Apher 1997, 1:191.
9. Ohta T, Kawaguchi H, Hattori M. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001, 71:628.
10. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephritic syndrome. Pediatr Nephrol 2005, 20:1660.
11. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Eng J Med 2006, 354:1961.
12. Gossmann J, Scheuermann E, Porubsky S, Kachel H, Geiger H, Hauser I. Abrogation of nephritic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007, 20:558.
13. Hristea D, Hadaya K, Marangon N. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007, 20:102.
14. Kamar N, Faguer S, Esposito L. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007, 67:250.
15. Yabu J, Ho B, Scandling J, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008, 8:222.
16. Meyer T, Thaiss F, Stahl R. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2007, 20:1066.
17. Bayrakci U, Baskin E, Sakalli H, Karakayali H, Haberal M. Rituximab for post-transplant recurrences of FSGS. Pediatr Transplantat 2009, 13:240.
18. Strologo LD, Guzzo I, Laurenzi C. Use of rituximab in focal glomerulosclerosis relapse after renal transplantation. Transplantation 2009, 88:417.
19. Marks SD, McGraw M. Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 2007, 22:158.
20. Peters H, Kar N, Wetzels J. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med 2008, 66:408.
21. Rodriguez-Ferrero M, Ampuero J, Anaya F. Rituximab and chronic plasmapheresis therapy of nephritic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Tranplant proc 2009, 41:2406.
22. Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephritic syndrome after rituximab therapy. Nephrol Dial Transplant 2008, 4:167.